9.52
0.00 (0.00%)
| Penutupan Terdahulu | 9.52 |
| Buka | 9.17 |
| Jumlah Dagangan | 50,880 |
| Purata Dagangan (3B) | 36,163 |
| Modal Pasaran | 417,844,256 |
| Harga / Pendapatan (P/E TTM) | 63.47 |
| Harga / Jualan (P/S) | 48.28 |
| Harga / Buku (P/B) | 13.91 |
| Julat 52 Minggu |
| Margin Keuntungan | 28.99% |
| Margin Operasi (TTM) | -68.64% |
| EPS Cair (TTM) | 0.050 |
| Pertumbuhan Hasil Suku Tahunan (YOY) | -36.10% |
| Pertumbuhan Pendapatan Suku Tahunan (YOY) | 136.50% |
| Nisbah Semasa (MRQ) | 10.71 |
| Aliran Tunai Operasi (OCF TTM) | 2.08 M |
| Aliran Tunai Bebas Leveraj (LFCF TTM) | 1.27 M |
| Pulangan Atas Aset (ROA TTM) | 7.18% |
| Pulangan Atas Ekuiti (ROE TTM) | 14.83% |
Arah Aliran Pasaran
| Jangka Pendek | Jangka Sederhana | ||
| Industri | Medical Instruments & Supplies (US) | Bercampur | Bercampur |
| Medical Instruments & Supplies (Global) | Menaik | Bercampur | |
| Stok | Anbio Biotechnology | - | - |
AISkor Stockmoo
| Konsensus Penganalisis | 0.0 |
| Aktiviti Orang Dalam | NA |
| Volatiliti Harga | 4.5 |
| Purata Bergerak Teknikal | 2.5 |
| Osilator Teknikal | -2.5 |
| Purata | 1.13 |
|
Anbio Biotechnology is a medical device company focused on in vitro diagnostics. The company's mission is to change the diagnostics market by personalizing and decentralizing the current diagnostic solutions for faster diagnosis to improve patient prognosis. The company proposes this by providing accessible and affordable diagnostic solutions globally at the forefront of science and offering laboratory, wellness, at-home, and point-of-care (POCT) in vitro diagnostic (IVD) solutions. The business planning is to focus on validating and commercializing the existing portfolio of in vitro diagnostic products, as well as generating additional data required to support regulatory submissions and compliance, including under frameworks such as the In Vitro Diagnostic Regulation (IVDR). |
|
| Sektor | Healthcare |
| Industri | Medical Instruments & Supplies |
| Gaya Pelaburan | Small Growth |
| % Dimiliki oleh Orang Dalam | 4.78% |
| % Dimiliki oleh Institusi | 4.94% |
Tiada data dalam julat masa ini.
Tiada data dalam julat masa ini.
Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.
Portfolio
| Keuntungan Nyata | - |
| Keuntungan Tidak Nyata | - |
| Dividen Diterima 2026 | - |
| Jumlah Untung | - |
| Pulangan Purata | - |
| Kuantiti (Beli) | - |
| Purata Harga (Beli) | - |
| Kuantiti (Jual) | - |
| Purata Harga (Jual) | - |